Worm M - Search Results

1

Sustained clinical efficacy of sublingual immunotherapy with a high-dose grass pollen extract.

Kuna P, Samolinski B, Worm M, Pfaar O, Klimek L; Study Group. Kuna P, et al. Among authors: worm m. Eur Ann Allergy Clin Immunol. 2011 Aug;43(4):117-21. Eur Ann Allergy Clin Immunol. 2011. PMID: 21980799 Clinical Trial.

2

Immunophenotypic characterization of peripheral B cells. During short-term immunotherapy with tree pollen allergoid and the immunoadjuvant monophosphoryl lipid A.

Röver AC, Reimann S, Zuberbier T, Worm M. Röver AC, et al. Among authors: worm m. J Investig Allergol Clin Immunol. 2002;12(4):227-34. J Investig Allergol Clin Immunol. 2002. PMID: 12926181 Clinical Trial.

3

Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.

Worm M. Worm M. Eur Ann Allergy Clin Immunol. 2006 Dec;38(10):355-60. Eur Ann Allergy Clin Immunol. 2006. PMID: 17274520 Clinical Trial.

4

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.

Didier A, Malling HJ, Worm M, Horak F, Jäger S, Montagut A, André C, de Beaumont O, Melac M. Didier A, et al. Among authors: worm m. J Allergy Clin Immunol. 2007 Dec;120(6):1338-45. doi: 10.1016/j.jaci.2007.07.046. Epub 2007 Nov 1. J Allergy Clin Immunol. 2007. PMID: 17935764 Clinical Trial.

5

Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy.

Didier A, Melac M, Montagut A, Lhéritier-Barrand M, Tabar A, Worm M. Didier A, et al. Among authors: worm m. Allergy. 2009 Jan;64(1):166-71. doi: 10.1111/j.1398-9995.2008.01767.x. Epub 2008 Dec 5. Allergy. 2009. PMID: 19076546 Clinical Trial.

6

Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment.

Horak F, Jaeger S, Worm M, Melac M, Didier A. Horak F, et al. Among authors: worm m. Clin Exp Allergy. 2009 Mar;39(3):394-400. doi: 10.1111/j.1365-2222.2008.03153.x. Epub 2008 Dec 23. Clin Exp Allergy. 2009. PMID: 19134018 Free PMC article. Clinical Trial.

7

'Well days' after sublingual immunotherapy with a high-dose 6-grass pollen preparation.

Worm M. Worm M. Allergy. 2009 Jul;64(7):1104-5. doi: 10.1111/j.1398-9995.2009.02041.x. Epub 2009 Apr 6. Allergy. 2009. PMID: 19385951 Clinical Trial. No abstract available.

8

Safety of a rush immunotherapy build-up schedule with depigmented polymerized allergen extracts.

Brehler R, Klimek L, Pfaar O, Hauswald B, Worm M, Bieber T. Brehler R, et al. Among authors: worm m. Allergy Asthma Proc. 2010 May-Jun;31(3):e31-8. doi: 10.2500/aap.2010.31.3334. Allergy Asthma Proc. 2010. PMID: 20615317

9

[Sublingual immunotherapy. Where are we now?].

Lee H, Zuberbier T, Worm M. Lee H, et al. Among authors: worm m. Hautarzt. 2011 Jun;62(6):467-74; quiz 475. doi: 10.1007/s00105-011-2173-2. Hautarzt. 2011. PMID: 21590356 German.

10

Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.

Didier A, Worm M, Horak F, Sussman G, de Beaumont O, Le Gall M, Melac M, Malling HJ. Didier A, et al. Among authors: worm m. J Allergy Clin Immunol. 2011 Sep;128(3):559-66. doi: 10.1016/j.jaci.2011.06.022. Epub 2011 Jul 29. J Allergy Clin Immunol. 2011. PMID: 21802126 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

728 results

Search Page

Filters